Risk factor
Considerable default risk
Profitability factor
Greatly undervalued vs peers
About
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalue
Target Price
The average target price of SYNC.L is 212 and suggests 117% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell